Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neutropenia 1Neoplasms 1Breast Neoplasms 1

Interventions

Cisplatin 516Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 341Paclitaxel 336Oxaliplatin 335Gemcitabine 323Docetaxel 316Fluorouracil 289Drug Therapy 276apatinib 247Bevacizumab 247camrelizumab 219Etoposide 201Irinotecan 181Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145Blood Specimen Collection 140anlotinib 139Pemetrexed 138Cytarabine 138toripalimab 134Surgical Procedures, Operative 131Radiosurgery 130S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Maxy G34 × Clear all
NCT00501332 2007-12-24

Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy

Maxygen Holdings Ltd.

Phase 2 Unknown
30 enrolled
Breast

Breast Neoplasms, Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡